Balermpas, P., Rödel, F., Rödel, C., Krause, M., Linge, A., Lohaus, F., Baumann, M., Tinhofer, I., Budach, V., Gkika, E., et al. (2016). CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG). Int. J. Cancer 138, 171–181.

Baumann, M., and Overgaard, J. (2016). Bridging the valley of death: The new Radiotherapy & Oncology section “First in man - Translational innovations in radiation oncology.” Radiother Oncol 118, 217–219.

Dickreuter, E., Eke, I., Krause, M., Borgmann, K., van Vugt, M.A., and Cordes, N. (2016). Targeting of β1 integrins impairs DNA repair for radiosensitization of head and neck cancer cells. Oncogene 35, 1353–1362.

Eke, I., Hehlgans, S., Sandfort, V., and Cordes, N. (2016). 3D matrix-based cell cultures: Automated analysis of tumor cell survival and proliferation. Int. J. Oncol. 48, 313–321.

Hofheinz, F., Bütof, R., Apostolova, I., Zöphel, K., Steffen, I.G., Amthauer, H., Kotzerke, J., Baumann, M., and van den Hoff, J. (2016). An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET. EJNMMI Res 6, 19.

Krause, M., Dubrovska, A., Linge, A., and Baumann, M. (2016). Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments. Adv. Drug Deliv. Rev.

Lattermann, A., Baumann, M., and Krause, M. (2016). Clinical trials for personalized glioblastoma radiotherapy: Markers for efficacy and late toxicity but often delayed treatment - Does that matter? Radiother Oncol 118, 211–213.

Linge, A., Lock, S., Gudziol, V., Nowak, A., Lohaus, F., von Neubeck, C., Jutz, M., Abdollahi, A., Debus, J., Tinhofer, I., et al. (2016). Low CSC marker expression and low hypoxia identify good prognosis subgroups in HPV(-)HNSCC after postoperative radiochemotherapy: a multicenter study of the DKTK-ROG. Clin. Cancer Res. 2016 [Epub ahead of print]

Offersen, B.V., Boersma, L.J., Kirkove, C., Hol, S., Aznar, M.C., Sola, A.B., Kirova, Y.M., Pignol, J.-P., Remouchamps, V., Verhoeven, K., et al. (2016). ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1. Radiother Oncol 118, 205–208.

Peitzsch, C., Cojoc, M., Hein, L., Kurth, I., Mӓbert, K., Trautmann, F., Klink, B., Schrock, E., Wirth, M.P., Krause, M., et al. (2016). An epigenetic reprogramming strategy to re-sensitize radioresistant prostate cancer cells. Cancer Res. 2016 [Epub ahead of print]

Petr, J., Platzek, I., Seidlitz, A., Mutsaerts, H.J.M.M., Hofheinz, F., Schramm, G., Maus, J., Beuthien-Baumann, B., Krause, M., and van den Hoff, J. (2016). Early and late effects of radiochemotherapy on cerebral blood flow in glioblastoma patients measured with non-invasive perfusion MRI. Radiother Oncol 118, 24–28.

Pilz, K., Hoffmann, A.L., Baumann, M., and Troost, E.G.C. (2016). Vertebral fractures - An underestimated side-effect in patients treated with radio(chemo)therapy. Radiother Oncol 118, 421–423.

Richter, C., Pausch, G., Barczyk, S., Priegnitz, M., Keitz, I., Thiele, J., Smeets, J., Stappen, F.V., Bombelli, L., Fiorini, C., et al. (2016). First clinical application of a prompt gamma based in vivo proton range verification system. Radiother Oncol 118, 232–237.

Storch, K., and Cordes, N. (2016). The impact of CDK9 on radiosensitivity, DNA damage repair and cell cycling of HNSCC cancer cells. Int. J. Oncol. 48, 191–198.

Tawk, B., Schwager, C., Deffaa, O., Dyckhoff, G., Warta, R., Linge, A., Krause, M., Weichert, W., Baumann, M., Herold-Mende, C., et al. (2016). Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma. Radiother Oncol 118, 350–358.

Tillner, F., Thute, P., Löck, S., Dietrich, A., Fursov, A., Haase, R., Lukas, M., Rimarzig, B., Sobiella, M., Krause, M., et al. (2016). Precise image-guided irradiation of small animals: a flexible non-profit platform. Phys Med Biol 61, 3084–3108.

Tinhofer, I., Budach, V., Saki, M., Konschak, R., Niehr, F., Jöhrens, K., Weichert, W., Linge, A., Lohaus, F., Krause, M., et al. (2016). Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation. Eur. J. Cancer 57, 78–86.




Abramyuk, A., Hietschold, V., Appold, S., von Kummer, R., and Abolmaali, N. (2015). Radiochemotherapy-induced changes of tumour vascularity and blood supply estimated by dynamic contrast-enhanced CT and fractal analysis in malignant head and neck tumours. Br J Radiol 88, 20140412.

Artacho-Cordón, F., Ríos-Arrabal, S., Olivares-Urbano, M.A., Storch, K., Dickreuter, E., Muñoz-Gámez, J.A., León, J., Calvente, I., Torné, P., Salinas, M.D.M., et al. (2015). Valproic acid modulates radiation-enhanced matrix metalloproteinase activity and invasion of breast cancer cells. Int. J. Radiat. Biol. 91, 946–956.

Atun, R., Jaffray, D.A., Barton, M.B., Bray, F., Baumann, M., Vikram, B., Hanna, T.P., Knaul, F.M., Lievens, Y., Lui, T.Y.M., et al. (2015). Expanding global access to radiotherapy. Lancet Oncol. 16, 1153–1186.

Balermpas, P., Rödel, F., Rödel, C., Krause, M., Linge, A., Lohaus, F., Baumann, M., Tinhofer, I., Budach, V., Gkika, E., et al. (2016). CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG). Int. J. Cancer 138, 171–181.

Beyreuther, E., Karsch, L., Laschinsky, L., Leßmann, E., Naumburger, D., Oppelt, M., Richter, C., Schürer, M., Woithe, J., and Pawelke, J. (2015). Radiobiological response to ultra-short pulsed megavoltage electron beams of ultra-high pulse dose rate. Int. J. Radiat. Biol. 1–10.

Brada, M., Pope, A., and Baumann, M. (2015). SABR in NSCLC - The beginning of the end or the end of the beginning? Radiother Oncol 114, 135–137.

Budach, V., Stromberger, C., Poettgen, C., Baumann, M., Budach, W., Grabenbauer, G., Marnitz, S., Olze, H., Wernecke, K.-D., and Ghadjar, P. (2015). Hyperfractionated accelerated radiation therapy (HART) of 70.6 Gy with concurrent 5-FU/Mitomycin C is superior to HART of 77.6 Gy alone in locally advanced head and neck cancer: long-term results of the ARO 95-06 randomized phase III trial. Int. J. Radiat. Oncol. Biol. Phys. 91, 916–924.

Bütof, R., and Krause, P.D.M. (2015). Tumorvolumenbestimmung. Onkologe 21, 382–387.

Bütof, R., Hofheinz, F., Zöphel, K., Stadelmann, T., Schmollack, J., Jentsch, C., Löck, S., Kotzerke, J., Baumann, M., and van den Hoff, J. (2015). Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma. J. Nucl. Med. 56, 1150–1156.

Castro Nava, A., Cojoc, M., Peitzsch, C., Cirillo, G., Kurth, I., Fuessel, S., Erdmann, K., Kunhardt, D., Vittorio, O., Hampel, S., et al. (2015). Development of novel radiochemotherapy approaches targeting prostate tumor progenitor cells using nanohybrids. Int. J. Cancer 137, 2492–2503.

Cobben, D.C.P., de Boer, H.C.J., Tijssen, R.H., Rutten, E.G.G.M., van Vulpen, M., Peerlings, J., Troost, E.G.C., Hoffmann, A.L., and van Lier, A.L.H.M.W. (2015). Emerging Role of MRI for Radiation Treatment Planning in Lung Cancer. Technol. Cancer Res. Treat. [Epub ahead of print]

Cojoc, M., Mäbert, K., Muders, M.H., and Dubrovska, A. (2015a). A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms. Semin. Cancer Biol. 31, 16–27.

Cojoc, M., Peitzsch, C., Kurth, I., Trautmann, F., Kunz-Schughart, L.A., Telegeev, G.D., Stakhovsky, E.A., Walker, J.R., Simin, K., Lyle, S., et al. (2015b). Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells. Cancer Res. 75, 1482–1494.

De Ryck, T., Van Impe, A., Vanhoecke, B.W., Heyerick, A., Vakaet, L., De Neve, W., Müller, D., Schmidt, M., Dörr, W., and Bracke, M.E. (2015). 8-prenylnaringenin and tamoxifen inhibit the shedding of irradiated epithelial cells and increase the latency period of radiation-induced oral mucositis : Cell culture and murine model. Strahlenther Onkol 191, 429–436.

Dickreuter, E., and Cordes, N. (2015). Cell-ECM interactions control DDR. Oncoscience 2, 679–680.

Dickreuter, E., Vehlow, A., and Cordes, N. (2015). 3D-Zellkultur zur Identifizierung von Zielmolekülen für die Krebstherapie. Biospektrum 21, 397–400.

Dickreuter, E., Eke, I., Krause, M., Borgmann, K., van Vugt, M.A., and Cordes, N. (2016). Targeting of β1 integrins impairs DNA repair for radiosensitization of head and neck cancer cells. Oncogene 35, 1353–1362.

Dietrich, A., Koi, L., Zöphel, K., Sihver, W., Kotzerke, J., Baumann, M., and Krause, M. (2015). Improving external beam radiotherapy by combination with internal irradiation. Br J Radiol 88, 20150042.

Ebert, N., Baumann, M., and Troost, E.G.C. (2015). Radiation-induced lung damage - Clinical risk profiles and predictive imaging on their way to risk-adapted individualized treatment planning? Radiother Oncol 117, 1–3.

Eke, I., and Cordes, N. (2015). Focal adhesion signaling and therapy resistance in cancer. Seminars in Cancer Biology 31, 65–75.

Eke, I., Hehlgans, S., Zong, Y., and Cordes, N. (2015a). Comprehensive analysis of signal transduction in three-dimensional ECM-based tumor cell cultures. J Biol Methods 2.

Eke, I., Zscheppang, K., Dickreuter, E., Hickmann, L., Mazzeo, E., Unger, K., Krause, M., and Cordes, N. (2015b). Simultaneous β1 integrin-EGFR Targeting and Radiosensitization of Human Head and Neck Cancer. J. Natl. Cancer Inst. 107.

Even, A.J.G., van der Stoep, J., Zegers, C.M.L., Reymen, B., Troost, E.G.C., Lambin, P., and van Elmpt, W. (2015). PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes. Radiother Oncol 116, 281–286.

Fischer, S., Soyez, K., and Gurtner, S. (2015). Adapting Scott and Bruce’s General Decision-Making Style Inventory to Patient Decision Making in Provider Choice. Med Decis Making 35, 525–532.

Gani, C., Coackley, C., Kumareswaran, R., Schütze, C., Krause, M., Zafarana, G., and Bristow, R.G. (2015). In vivo studies of the PARP inhibitor, AZD-2281, in combination with fractionated radiotherapy: An exploration of the therapeutic ratio. Radiother Oncol 116, 486–494.

Gehler, S., Löck, S., Shinohara, S., Bäcker, A., Ketzmerick, R., Kuhl, U., and Stöckmann, H.-J. (2015). Experimental Observation of Resonance-Assisted Tunneling. Phys. Rev. Lett. 115, 104101.

Ghadjar, P., Hayoz, S., Bernhard, J., Zwahlen, D.R., Hölscher, T., Gut, P., Guckenberger, M., Hildebrandt, G., Müller, A.-C., Plasswilm, L., et al. (2015). Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10. J. Clin. Oncol. 33, 4158–4166.

Gotz, M., Karsch, L., and Pawelke, J. (2015). Comparative investigation of three dose rate meters for their viability in pulsed radiation fields. J Radiol Prot 35, 415–428.

Gotz, M., Karsch, L., and Pawelke, J. Ortsdosimetrie in gepulsten Strahlungsfeldern.

Gruber, S., Hamedinger, D., Bozsaky, E., Schmidt, M., Wolfram, K., Haagen, J., Habelt, B., Puttrich, M., and Dörr, W. (2015a). Local hypoxia in oral mucosa (mouse) during daily fractionated irradiation - Effect of pentoxifylline. Radiother Oncol 116, 404–408.

Gruber, S., Schmidt, M., Bozsaky, E., Wolfram, K., Haagen, J., Habelt, B., Puttrich, M., and Dörr, W. (2015b). Modulation of radiation-induced oral mucositis by pentoxifylline: preclinical studies. Strahlenther Onkol 191, 242–247.

Guckenberger, M., Klement, R.J., Allgäuer, M., Andratschke, N., Blanck, O., Boda-Heggemann, J., Dieckmann, K., Duma, M., Ernst, I., Ganswindt, U., et al. (2015). Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy. Radiother Oncol.

Gurtner, K., and Baumann, M. (2015). [Proton therapy of pediatric rhabdomyosarcoma : Same tumor control as photon therapy, with less adverse effects]. Strahlenther Onkol 191, 814–816.

Hausmann, C., Temme, A., Cordes, N., and Eke, I. (2015). ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation. Oncotarget 6, 34592–34605.

Helmbrecht, S., Kuess, P., Birkfellner, W., Enghardt, W., Stützer, K., Georg, D., and Fiedler, F. (2015). Systematic analysis on the achievable accuracy of PT-PET through automated evaluation techniques. Zeitschrift Für Medizinische Physik 25, 146–155.

Hendriks, L.E., Derks, J.L., Postmus, P.E., Damhuis, R.A., Houben, R.M.A., Troost, E.G.C., Hochstenbag, M.M., Smit, E.F., and Dingemans, A.-M.C. (2015). Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study. Eur. J. Cancer 51, 2534–2544.

Hermans, B.C.M., Persoon, L.C.G.G., Podesta, M., Hoebers, F.J.P., Verhaegen, F., and Troost, E.G.C. (2015). Weekly kilovoltage cone-beam computed tomography for detection of dose discrepancies during (chemo)radiotherapy for head and neck cancer. Acta Oncol 54, 1483–1489.

Herrmann, T., Geyer, P., and Appold, S. (2015). The mean lung dose (MLD) : Predictive criterion for lung damage? Strahlenther Onkol 191, 557–565.

Hofheinz, F., Lougovski, A., Zöphel, K., Hentschel, M., Steffen, I.G., Apostolova, I., Wedel, F., Buchert, R., Baumann, M., Brenner, W., et al. (2015). Increased evidence for the prognostic value of primary tumor asphericity in pretherapeutic FDG PET for risk stratification in patients with head and neck cancer. Eur. J. Nucl. Med. Mol. Imaging 42, 429–437.

Hofmann, K.M., Masood, U., Pawelke, J., and Wilkens, J.J. (2015). A treatment planning study to assess the feasibility of laser-driven proton therapy using a compact gantry design. Med Phys 42, 5120.

Hueso-González, F., Biegun, A.K., Dendooven, P., Enghardt, W., Fiedler, F., Golnik, C., Heidel, K., Kormoll, T., J. Petzoldt, Römer, K.E., et al. (2015a). Comparison of LSO and BGO block detectors for prompt gamma imaging in ion beam therapy. J. Inst. 10, P09015.

Hueso-González, F., Enghardt, W., Fiedler, F., Golnik, C., Janssens, G., Petzoldt, J., Prieels, D., Priegnitz, M., Römer, K.E., Smeets, J., et al. (2015b). First test of the prompt gamma ray timing method with heterogeneous targets at a clinical proton therapy facility. Phys Med Biol 60, 6247–6272.

Hueso-González, F., Vijande, J., Ballester, F., Perez-Calatayud, J., and Siebert, F.-A. (2015c). A simple analytical method for heterogeneity corrections in low dose rate prostate brachytherapy. Phys Med Biol 60, 5455–5469.

Iwanowska, J., Swiderski, L., Krakowski, T., Moszynski, M., Szczesniak, T., and Pausch, G. (2015). The time-of-flight method for characterizing the neutron response of liquid organic scintillators. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment 781, 44–49.

Jaffray, D.A., Atun, R., Barton, M., Baumann, M., Gospodarowicz, M., Hoskin, P., Knaul, F.M., Lievens, Y., Rosenblatt, E., Torode, J., et al. (2015a). Radiation therapy and the global health agenda. Clin Oncol (R Coll Radiol) 27, 67–69.

Jaffray, D.A., Knaul, F.M., Atun, R., Adams, C., Barton, M.B., Baumann, M., Lievens, Y., Lui, T.Y.M., Rodin, D.L., Rosenblatt, E., et al. (2015b). Global Task Force on Radiotherapy for Cancer Control. Lancet Oncol. 16, 1144–1146.

Jakobi, A., Bandurska-Luque, A., Stützer, K., Haase, R., Löck, S., Wack, L.-J., Mönnich, D., Thorwarth, D., Perez, D., Lühr, A., et al. (2015a). Identification of Patient Benefit From Proton Therapy for Advanced Head and Neck Cancer Patients Based on Individual and Subgroup Normal Tissue Complication Probability Analysis. Int. J. Radiat. Oncol. Biol. Phys. 92, 1165–1174.

Jakobi, A., Lühr, A., Stützer, K., Bandurska-Luque, A., Löck, S., Krause, M., Baumann, M., Perrin, R., and Richter, C. (2015b). Increase in Tumor Control and Normal Tissue Complication Probabilities in Advanced Head-and-Neck Cancer for Dose-Escalated Intensity-Modulated Photon and Proton Therapy. Front Oncol 5, 256.

Jakobi, A., Stützer, K., Bandurska-Luque, A., Löck, S., Haase, R., Wack, L.-J., Mönnich, D., Thorwarth, D., Perez, D., Lühr, A., et al. (2015c). NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy. Acta Oncol 1–7.

Jentsch, C., Beuthien-Baumann, B., Troost, E.G.C., and Shakirin, G. (2015). Validation of functional imaging as a biomarker for radiation treatment response. Br J Radiol 20150014.

Juratli, T.A., Lautenschläger, T., Geiger, K.D., Pinzer, T., Krause, M., Schackert, G., and Krex, D. (2015). Radio-chemotherapy improves survival in IDH-mutant, 1p/19q non-codeleted secondary high-grade astrocytoma patients. J. Neurooncol. 124, 197–205.

Krause, M., and Gurtner, K. (2015). Radiation therapy of early breast cancer. Onkologe 21, 239–244.

Krause, M., and Supiot, S. (2015). Advances in Radiotherapy special feature. Br J Radiol 20150412.

Krause, M., Petersen, C., Offersen, B.V., and Baumann, M. (2015). Regional radiotherapy in high-risk breast cancer: is the issue solved? Br J Radiol 88, 20150071.

Kriegs, M., Gurtner, K., Can, Y., Brammer, I., Rieckmann, T., Oertel, R., Wysocki, M., Dorniok, F., Gal, A., Grob, T.J., et al. (2015). Radiosensitization of NSCLC cells by EGFR inhibition is the result of an enhanced p53-dependent G1 arrest. Radiother Oncol 115, 120–127.

Kuhlmann, J.D., Hein, L., Kurth, I., Wimberger, P., and Dubrovska, A. (2015). Targeting Cancer Stem Cells: Promises and Challenges. Anticancer Agents Med Chem 16, 38–58.

Kurth, I., Hein, L., Mäbert, K., Peitzsch, C., Koi, L., Cojoc, M., Kunz-Schughart, L., Baumann, M., and Dubrovska, A. (2015). Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma. Oncotarget 6, 34494–34509.

Kurz, C., Bauer, J., Unholtz, D., Richter, D., Stützer, K., Bert, C., and Parodi, K. (2015). 4D offline PET-based treatment verification in scanned ion beam therapy: a phantom study. Phys Med Biol 60, 6227–6246.

Löck, S., Roth, K., Skripcak, T., Worbs, M., Helmbrecht, S., Jakobi, A., Just, U., Krause, M., Baumann, M., Enghardt, W., et al. (2015). Implementation of a software for REmote COMparison of PARticlE and photon treatment plans: ReCompare. Z Med Phys 25, 287–294.

Lohaus, F., Linge, A., and Baumann, M. (2015). HPV and beyond-looking out for biomarkers for distinguishing the good prognosis from the bad prognosis group in locally advanced and clinically high risk HNSCC. Ann Transl Med 3, 255.

Menegakis, A., De Colle, C., Yaromina, A., Hennenlotter, J., Stenzl, A., Scharpf, M., Fend, F., Noell, S., Tatagiba, M., Brucker, S., et al. (2015a). Residual γH2AX foci after ex vivo irradiation of patient samples with known tumour-type specific differences in radio-responsiveness. Radiother Oncol 116, 480–485.

Menegakis, A., von Neubeck, C., Yaromina, A., Thames, H., Hering, S., Hennenlotter, J., Scharpf, M., Noell, S., Krause, M., Zips, D., et al. (2015b). γH2AX assay in ex vivo irradiated tumour specimens: A novel method to determine tumour radiation sensitivity in patient-derived material. Radiother Oncol 116, 473–479.

von Neubeck, C., Seidlitz, A., Kitzler, H.H., Beuthien-Baumann, B., and Krause, M. (2015a). Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs. Br J Radiol 88, 20150354.

von Neubeck, C., Geniza, M.J., Kauer, P.M., Robinson, R.J., Chrisler, W.B., and Sowa, M.B. (2015b). The effect of low dose ionizing radiation on homeostasis and functional integrity in an organotypic human skin model. Mutat. Res. 775, 10–18.

Offersen, B.V., Boersma, L.J., Kirkove, C., Hol, S., Aznar, M.C., Biete Sola, A., Kirova, Y.M., Pignol, J.-P., Remouchamps, V., Verhoeven, K., et al. (2015). ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol 114, 3–10.

Oppelt, M., Baumann, M., Bergmann, R., Beyreuther, E., Brüchner, K., Hartmann, J., Karsch, L., Krause, M., Laschinsky, L., Leßmann, E., et al. (2015). Comparison study of in vivo dose response to laser-driven versus conventional electron beam. Radiat Environ Biophys 54, 155–166.

Patties, I., Haagen, J., Dörr, W., Hildebrandt, G., and Glasow, A. (2015). Late inflammatory and thrombotic changes in irradiated hearts of C57BL/6 wild-type and atherosclerosis-prone ApoE-deficient mice. Strahlenther Onkol 191, 172–179.

Pavlyk, I., Rzhepetskyy, Y., Jagielski, A.K., Drozak, J., Wasik, A., Pereverzieva, G., Olchowik, M., Kunz-Schugart, L.A., Stasyk, O., and Redowicz, M.J. (2015). Arginine deprivation affects glioblastoma cell adhesion, invasiveness and actin cytoskeleton organization by impairment of β-actin arginylation. Amino Acids 47, 199–212.

Persoon, L.C.G.G., Podesta, M., Hoffmann, L., Sanizadeh, A., Schyns, L.E.J.R., de Ruiter, B.-M., Nijsten, S.M.J.J.G., Muren, L.P., Troost, E.G.C., and Verhaegen, F. (2015). Is integrated transit planar portal dosimetry able to detect geometric changes in lung cancer patients treated with volumetric modulated arc therapy? Acta Oncol 1–7.

Poitrasson-Rivière, A., Maestas, B.A., Hamel, M.C., Clarke, S.D., Flaska, M., Pozzi, S.A., Pausch, G., Herbach, C.-M., Gueorguiev, A., Ohmes, M.F., et al. (2015). Monte Carlo investigation of a high-efficiency, two-plane Compton camera for long-range localization of radioactive materials. Progress in Nuclear Energy 81, 127–133.

Poschau, M., Dickreuter, E., Singh-Müller, J., Zscheppang, K., Eke, I., Liersch, T., and Cordes, N. (2015). EGFR and β1-integrin targeting differentially affect colorectal carcinoma cell radiosensitivity and invasion. Radiother Oncol 116, 510–516.

Roemer, K., Pausch, G., Bemmerer, D., Berthel, M., Dreyer, A., Golnik, C., Hueso-González, F., Kormoll, T., J. Petzoldt, Rohling, H., et al. (2015). Characterization of scintillator crystals for usage as prompt gamma monitors in particle therapy. J. Inst. 10, P10033.

Rohling, H., Golnik, C., Enghardt, W., Hueso-Gonzalez, F., Kormoll, T., Pausch, G., Schumann, A., and Fiedler, F. (2015). Simulation Study of a Combined Pair Production #x2013; Compton Camera for In-Vivo Dosimetry During Therapeutic Proton Irradiation. IEEE Transactions on Nuclear Science 62, 2023–2030.

Rossow, L., Eke, I., Dickreuter, E., and Cordes, N. (2015). Targeting of the EGFR/β1 integrin connecting proteins PINCH1 and Nck2 radiosensitizes three-dimensional SCC cell cultures. Oncol. Rep. 34, 469–476.

Schanne, D.H., Nestle, U., Allgäuer, M., Andratschke, N., Appold, S., Dieckmann, U., Ernst, I., Ganswindt, U., Grosu, A.L., Holy, R., et al. (2015). Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysis. Strahlenther Onkol 191, 125–132.

Schumann, A., Petzoldt, J., Dendooven, P., Enghardt, W., Golnik, C., Hueso-González, F., Kormoll, T., Pausch, G., Roemer, K., and Fiedler, F. (2015). Simulation and experimental verification of prompt gamma-ray emissions during proton irradiation. Phys Med Biol 60, 4197–4207.

Schürer, M., Walter, A., Brünner, H., and Langenbucher, A. (2015). [Effect of transparent yellow and orange colored contact lenses on color discrimination in the yellow color range]. Ophthalmologe 112, 670–678.

Schürer, M., Walter, A., Brünner, H., and Langenbucher, A. (2015). [Erratum to: Effect of transparent yellow and orange colored contact lenses on color discrimination in the yellow color range]. Ophthalmologe 112, 869.

Seidlitz, A., Siepmann, T., Löck, S., Juratli, T., Baumann, M., and Krause, M. (2015). Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme. Radiat Oncol 10, 172.

Simon, M., Habeck, M., Büttner, D., Habeck, U., Nölling, T., Krause, M., Brix, G., Willich, N., Wenz, F., Schmidberger, H., et al. (2015). [Approval procedures for clinical trials in the field of radiation oncology]. Strahlenther Onkol.

Skripcak, T., Just, U., Simon, M., Buttner, D., Luhr, A., Baumann, M., and Krause, M. (2015). Towards Distributed Conduction of Large Scale Studies in Radiation Therapy and Oncology: open source system integration approach. IEEE Journal of Biomedical and Health Informatics PP, 1–1.

Steglich, A., Vehlow, A., Eke, I., and Cordes, N. (2015). α integrin targeting for radiosensitization of three-dimensionally grown human head and neck squamous cell carcinoma cells. Cancer Lett. 357, 542–548.

Storch, K., Sagerer, A., and Cordes, N. (2015). Cytotoxic and radiosensitizing effects of FAK targeting in human glioblastoma cells in vitro. Oncol. Rep. 33, 2009–2016.

Tawk, B., Schwager, C., Deffaa, O., Dyckhoff, G., Warta, R., Linge, A., Krause, M., Weichert, W., Baumann, M., Herold-Mende, C., et al. (2015). Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma. Radiother Oncol.

Trani, D., Yaromina, A., Dubois, L., Granzier, M., Peeters, S.G.J.A., Biemans, R., Nalbantov, G., Lieuwes, N., Reniers, B., Troost, E.E.G.C., et al. (2015). Preclinical Assessment of Efficacy of Radiation Dose Painting Based on Intratumoral FDG-PET Uptake. Clin. Cancer Res. 21, 5511–5518.

Troost, E.G.C. (2016). [Stereotactic radiotherapy augments the immune response]. Strahlenther Onkol 192, 70–71.

Troost, E.G.C. CUP Syndrom – Standard- und experimentelle Therapieansätze. Mitteilungsblatt der Sächsischen Krebsgesellschaft.

Troost, E.G.C. Kurative Strahlentherapie des Lungenkarzinoms - Möglichkeiten und Grenzen der individualisierten Behandlung. Mitteilungsblatt der Sächsischen Krebsgesellschaft.

Troost, E.G.C., Thorwarth, D., and Oyen, W.J.G. (2015). Imaging-Based Treatment Adaptation in Radiation Oncology. J. Nucl. Med. 56, 1922–1929.

Wack, L.J., Mönnich, D., van Elmpt, W., Zegers, C.M.L., Troost, E.G.C., Zips, D., and Thorwarth, D. (2015). Comparison of [18F]-FMISO, [18F]-FAZA and [18F]-HX4 for PET imaging of hypoxia--a simulation study. Acta Oncol 54, 1370–1377.

Wijsman, R., Dankers, F., Troost, E.G.C., Hoffmann, A.L., van der Heijden, E.H.F.M., de Geus-Oei, L.-F., and Bussink, J. (2015). Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-) radiotherapy. Radiother Oncol 117, 49–54.

Willers, H., Gheorghiu, L., Liu, Q., Efstathiou, J.A., Wirth, L.J., Krause, M., and von Neubeck, C. (2015). DNA Damage Response Assessments in Human Tumor Samples Provide Functional Biomarkers of Radiosensitivity. Semin Radiat Oncol 25, 237–250.

Zegers, C.M.L., van Elmpt, W., Hoebers, F.J.P., Troost, E.G.C., Öllers, M.C., Mottaghy, F.M., and Lambin, P. (2015). Imaging of tumour hypoxia and metabolism in patients with head and neck squamous cell carcinoma. Acta Oncol 54, 1378–1384.

Zienert, E., Eke, I., Aust, D., and Cordes, N. (2015). LIM-only protein FHL2 critically determines survival and radioresistance of pancreatic cancer cells. Cancer Lett. 364, 17–24.

Zschaeck, S., Haase, R., Abolmaali, N., Perrin, R., Stützer, K., Appold, S., Steinbach, J., Kotzerke, J., Zips, D., Richter, C., et al. (2015). Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure. Acta Oncol 54, 1355–1363.



Baumann M, Overgaard J (2014) What next? Radiother Oncol 110: 1–2

Blaes J, Weiler M, Sahm F, Hentschel B, Osswald M, Czabanka M, Thomé CM, Schliesser MG, Pusch S, Luger S, Winkler F, Radbruch A, Jugold M, Simon M, Steinbach JP, Schackert G, Tatagiba M, Westphal M, Tonn JC, Gramatzki D, Pietsch T, Hartmann C, Glimm H, Vaikoczy P, von Deimling A, Platten M, Weller M, Wick W (2014) NDRG1 prognosticates the natural course of disease in WHO grade II glioma. J Neurooncol 117: 25–32

Brüchner K, Beyreuther E, Baumann M, Krause M, Oppelt M, Pawelke J (2014) Establishment of a small animal tumour model for in vivo studies with low energy laser accelerated particles. Radiat Oncol 9: 57

Bütof R, Kirchner K, Appold S, Löck S, Rolle A, Höffken G, Krause M, Baumann M (2014) Potential clinical predictors of outcome after postoperative radiotherapy of non-small cell lung cancer. Strahlenther Onkol 190: 263–269

Dubrovska A (2014) Report on the International Workshop “Cancer stem cells: the mechanisms of radioresistance and biomarker discovery.” Int J Radiat Biol 90: 607–614

Helbig L, Koi L, Brüchner K, Gurtner K, Hess-Stumpp H, Unterschemmann K, Baumann M, Zips D, Yaromina A (2014) BAY 87-2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts. Radiat Oncol 9: 207

Helbig L, Koi L, Brüchner K, Gurtner K, Hess-Stumpp H, Unterschemmann K, Pruschy M, Baumann M, Yaromina A, Zips D (2014) Hypoxia-inducible factor pathway inhibition resolves tumor hypoxia and improves local tumor control after single-dose irradiation. Int J Radiat Oncol Biol Phys 88: 159–166

Knopf A, Nill S, Yohannes I, Graeff C, Dowdell S, Kurz C, Sonke J-J, Biegun AK, Lang S, McClelland J, Champion B, Fast M, Wölfelschneider J, Gianoli C, Rucinski A, Baroni G, Richter C, van de Water S, Grassberger C, Weber D, Poulsen P, Shimizu S, Bert C (2014) Challenges of radiotherapy: report on the 4D treatment planning workshop 2013. Phys Med 30: 809–815

Koi L, Bergmann R, Brüchner K, Pietzsch J, Pietzsch H-J, Krause M, Steinbach J, Zips D, Baumann M (2014) Radiolabeled anti-EGFR-antibody improves local tumor control after external beam radiotherapy and offers theragnostic potential. Radiother Oncol 110: 362–369

Linge A, Maurya P, Friedrich K, Baretton GB, Kelly S, Henry M, Clynes M, Larkin A, Meleady P (2014). Identification and functional validation of RAD23B as a potential protein in human breast cancer progression. J Proteome Res 13: 3212–3222

Lühr A, Löck S, Roth K, Helmbrecht S, Jakobi A, Petersen JB, Just U, Krause M, Enghardt W, Baumann M (2014) Concept for individualized patient allocation: ReCompare--remote comparison of particle and photon treatment plans. Radiat Oncol 9: 59

Peitzsch C, Perrin R, Hill RP, Dubrovska A, Kurth I (2014) Hypoxia as a biomarker for radioresistant cancer stem cells. Int J Radiat Biol 90: 636–652

Pirkkanen J, von Neubeck C, Sowa M (2014) Summary of an integrated experimental and computational approach to study the effects of heavy ion exposures on skin. NasaTHREE

Reifenberger G, Weber RG, Riehmer V, Kaulich, K, Willscher, E, Wirth, H, Gietzelt, J, Hentschel, B, Westphal, M, Simon, M, Schackert G, Schramm J, Matschke J, Sabel MC, Gramatzki D, Felsberg J, Hartmann C, Steinbach JP, Schlegel U, Wick W, Radlwimmer B, Pietsch T, Tonn JC, von Deimling A, Binder H, Weller M, Loeffler M, German Glioma Network (2014) Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling. Int J Cancer 135: 1822–1831

Richter C, Seco J, Hong TS, Duda DG, Bortfeld T (2014) Radiation-induced changes in hepatocyte-specific Gd-EOB-DTPA enhanced MRI: potential mechanism. Med Hypotheses 83: 477–481

Schmidt M, Haagen J, Noack R, Siegemund A, Gabriel P, Dörr W (2014) Effects of bone marrow or mesenchymal stem cell transplantation on oral mucositis (mouse) induced by fractionated irradiation. Strahlenther Onkol 190: 399–404

Schmidt M, Piro-Hussong A, Siegemund A, Gabriel P, Dörr W (2014) Modification of radiation-induced oral mucositis (mouse) by adult stem cell therapy: single-dose irradiation. Radiat Environ Biophys 53: 629–634

Schütze C, Bergmann R, Brüchner K, Mosch B, Yaromina A, Zips D, Hessel F, Krause M, Thames H, Kotzerke J, Steinbach J, Baumann M, Beuthien-Baumann B (2014) Effect of [(18)F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice. Radiother Oncol 111: 81–87

Skripcak T, Belka C, Bosch W, Brink C, Brunner T, Budach V, Büttner D, Debus J, Dekker A, Grau C, Gulliford S, Hurkmans C, Just U, Krause M, Lambin P, Langendijk JA, Lewensohn R, Lühr A, Maingon P, Masucci M, Niyazi M, Poortmans P, Simon M, Schmidberger H, Spezi E, Stuschke M, Valentini V, Verheij M, Whitfield G, Zackrisson B, Zips D, Baumann M (2014) Creating a data exchange strategy for radiotherapy research: Towards federated databases and anonymized public datasets. Radiother Oncol: 303-309

Tillner F, Thute P, Bütof R, Krause M, Enghardt W (2014) Preclinical research in small animals using radiotherapy technology - a bidirectional translational approach. Z Med Phys

Trautmann F, Cojoc M, Kurth I, Melin N, Bouchez LC, Dubrovska A, Peitzsch C (2014) CXCR4 as biomarker for radioresistant cancer stem cells. Int. J. Radiat. Biol. 90: 687–699

Von Bonin M, Bornhäuser M (2014) Concise review: the bone marrow niche as a target of graft versus host disease. Stem Cells 32: 1420–1428

Wang M, Kern AM, Hülskötter M, Greninger P, Singh A, Pan Y, Chowdhury D, Krause M, Baumann M, Benes CH, Efstathiou JA, Settleman J, Willers H (2014) EGFR-mediated chromatin condensation protects KRAS-mutant cancer calls against ionizing radiation. Cancer Res 74: 2825-2834



Eke I, Storch K, Krause M, Cordes N (2013) Cetuximab attenuates its cytotoxic and radiosensitizing potential by inducing fibronectin biosynthesis. Cancer Res 73: 5869–5879

Koch U, Höhne K, von Neubeck C, Thames HD, Yaromina A, Dahm-Daphi J, Baumann M, Krause M (2013) Residual γH2AX foci predict local tumour control after radiotherapy. Radiother Oncol 108: 434–439

Krause M, Kummer B, Deparade A, Eicheler W, Pfitzmann D, Yaromina A, Kunz-Schughart L.A, Baumann M (2013) Simultaneous PLK1 inhibition improves local tumour control after fractionated irradiation. Radiother Oncol 108: 422–428

Tinganelli W, Ma N-Y, Von Neubeck C, Maier A, Schicker C, Kraft-Weyrather W, Durante M (2013) Influence of acute hypoxia and radiation quality on cell survival. J Radiat Res 54 Suppl 1: i23–i30

Von Neubeck C, Shankaran H, Geniza MJ, Kauer PM, Robinson RJ, Chrisler WB, Sowa MB (2013) Integrated experimental and computational approach to understand the effects of heavy ion radiation on skin homeostasis. Integr Biol (Camb) 5: 1229–1243